bio

Mirotrix Bio Silky Treatment by Safa Dream Salon: A Revolution in Hair Care

Mirotrix Bio Silky Treatment by Safa Dream Salon: A Revolution in Hair Care

Mirotrix Bio Silky Treatment by Safa Dream Salon: A Revolution in Hair Care

admin October 3, 2024

As the world of hair care continues to evolve, the quest for the perfect treatment that combines...

IASO Bio Establishes International CAR-T Diagnostic and Treatment Center in China to Serve MM Patients Worldwide

IASO Bio Establishes International CAR-T Diagnostic and Treatment Center in China to Serve MM Patients Worldwide

AETOSWire November 21, 2023

NANJING, China — Nanjing IASO Biotechnology Co., Ltd. (IASO Bio) made its debut at the 6th China International...

Natalia BELINSKAIA, BIO

Natalia BELINSKAIA, BIO

Natalia BELINSKAIA, BIO

admin July 13, 2023

On June 8, 2023 in Dubai UAE the legendary annual business award ceremony “Mrs lady of the...

Hevolution Foundation to Host Panel on Healthspan Investing at 2023 BIO International Convention

Hevolution Foundation to Host Panel on Healthspan Investing at 2023 BIO International Convention

Hevolution Foundation to Host Panel on Healthspan Investing at 2023 BIO International Convention

AETOSWire June 2, 2023

RIYADH, Saudi Arabia — Hevolution Foundation, a global non-profit organization that provides grants and early-stage investments to...

Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform

Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform

AETOSWire January 25, 2023

WARREN, N.J. — Tevogen Bio today announced positive topline results from its Proof-of-Concept (POC) clinical trial designed to evaluate the safety...

Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis

Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis

Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis

AETOSWire December 6, 2022

WARREN, N.J.: Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in...

Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

AETOSWire November 24, 2022

WARREN, N.J.: Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in...